- Home
- PRPL vs GNLX Comparison
PRPL vs GNLX Comparison
Compare PRPL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- GNLX
- Stock Information
- Founded
- PRPL 2010
- GNLX 2001
- Country
- PRPL United States
- GNLX United States
- Employees
- PRPL N/A
- GNLX N/A
- Industry
- PRPL Home Furnishings
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- PRPL Consumer Discretionary
- GNLX Health Care
- Exchange
- PRPL Nasdaq
- GNLX Nasdaq
- Market Cap
- PRPL 125.6M
- GNLX 128.0M
- IPO Year
- PRPL N/A
- GNLX 2023
- Fundamental
- Price
- PRPL $1.05
- GNLX $3.92
- Analyst Decision
- PRPL Hold
- GNLX Strong Buy
- Analyst Count
- PRPL 1
- GNLX 4
- Target Price
- PRPL $1.00
- GNLX $17.75
- AVG Volume (30 Days)
- PRPL 530.9K
- GNLX 132.9K
- Earning Date
- PRPL 11-03-2025
- GNLX 11-13-2025
- Dividend Yield
- PRPL N/A
- GNLX N/A
- EPS Growth
- PRPL N/A
- GNLX N/A
- EPS
- PRPL N/A
- GNLX N/A
- Revenue
- PRPL $456,844,000.00
- GNLX N/A
- Revenue This Year
- PRPL N/A
- GNLX N/A
- Revenue Next Year
- PRPL $11.87
- GNLX N/A
- P/E Ratio
- PRPL N/A
- GNLX N/A
- Revenue Growth
- PRPL N/A
- GNLX N/A
- 52 Week Low
- PRPL $0.56
- GNLX $1.95
- 52 Week High
- PRPL $1.29
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- PRPL 51.37
- GNLX 62.72
- Support Level
- PRPL $1.01
- GNLX $3.56
- Resistance Level
- PRPL $1.11
- GNLX $3.61
- Average True Range (ATR)
- PRPL 0.07
- GNLX 0.23
- MACD
- PRPL -0.02
- GNLX 0.04
- Stochastic Oscillator
- PRPL 16.00
- GNLX 88.57
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.